Market Name: Tasmar

Generic Name: Tolcapone

Tasmar is an adjunct oral therapy designed for use in conjunction with other Parkinson’s medications. These medications include carbidopa and levidopa.

The FDA added a black box warning to the prescribing information for Tasmar in January 2007 based on reports of serious liver problems and death associated with use.

Black Box Warning Date: January 2007

FDA Link: Tasmar